Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin and Corticosteroids in Non-HIV Pneumocystis Pneumonia
NCT02603575Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Nov 2015
- Primary completion
- Dec 2020
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of caspofungin and methylprednisolone in pneumocystis pneumonia (PCP) (4 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: 28-day Mortality. Status: unknown.
02
Drugs
caspofunginmethylprednisolone
03
Conditions
pneumocystis pneumonia (PCP)
Beyond the preview
Go deeper on NCT02603575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02603575.